Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
02/01/2012 | CN101816690B 人参总皂苷双层渗透泵片及其制备方法 TSPG layer osmotic pump tablets and its preparation method |
02/01/2012 | CN101768569B 一种神经细胞诱导剂及其应用 Neural cell inducer and its application |
02/01/2012 | CN101700230B 一种单唾液酸四己糖神经节苷酯微球及其制备方法 A single-sialic four hexose ganglioside microsphere and its preparation method |
02/01/2012 | CN101623126B 烟用中药降毒戒烟加香添加液的制备工艺 Cigarette smoking cessation medicine drop drug preparation process to add liquid perfuming |
02/01/2012 | CN101622259B 作为nk3拮抗剂的螺哌啶衍生物 As nk3 antagonists spiro piperidine derivative |
02/01/2012 | CN101590008B 一种24-亚甲基环木菠萝醇阿魏酸酯的组合物制剂和纯化工艺 One kind 24- composition formulation of methylene ring jackfruit alcohol ferulic acid and purification process |
02/01/2012 | CN101541337B 迷迭香提取物、包含它们的膳食和药物组合物及其用途 Rosemary extract, containing their dietary and pharmaceutical compositions and their use |
02/01/2012 | CN101528709B 对痕量胺相关受体有亲和性的氨基甲基-2-咪唑类 The trace amine associated receptors have affinity for the amino-methyl-2-imidazole |
02/01/2012 | CN101522638B 哒嗪酮衍生物 Pyridazinones |
02/01/2012 | CN101273045B 7-[2-[4-(6-氟-3-甲基-1,2-苯并异*唑-5-基)-1-哌嗪基]乙基]-2-(1-丙炔基)-7H-吡唑-[4,3-e]-[1,2,4]-三唑-[1,5-c]嘧啶-5-胺 7- [2- [4- (6-fluoro-3-methyl-1,2-benzisoxazol * 5-yl) -1-piperazinyl] ethyl] -2- (1-propynyl yl) -7H- pyrazolo - [4,3-e] - [1,2,4] - triazolo - [1,5-c] pyrimidine-5-amine |
02/01/2012 | CN101264090B 一种治疗牙疼的药物 A method of treating toothache medicine |
02/01/2012 | CN101247795B 用于治疗与中枢神经系统(cns)相关疾病的方法和组合物 A method for the treatment of central nervous system (cns) related diseases and compositions |
02/01/2012 | CN101152318B 一种用于调神、调心、调胃和调肠的中药 A Tiaoshen, aligning, adjusting the stomach and intestines tune medicine |
02/01/2012 | CN101147586B 一种改善睡眠的保健食品 A method for improving sleep health food |
01/31/2012 | US8106218 Pharmaceutical compounds |
01/31/2012 | US8106213 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
01/31/2012 | US8106164 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
01/31/2012 | US8106153 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
01/31/2012 | US8106097 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
01/31/2012 | US8106068 Compositions and methods for modulating c-kit and PDGFR receptors |
01/31/2012 | US8106063 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
01/31/2012 | US8106050 Derivatives of pyrrolo-pyrazines having a kinase inhibitory activity and their biological applications |
01/31/2012 | US8106044 8-{4-[3-(5-fluoro-1H-indol-3-yl)-propyl]-piperazin-1-yl}-2-methyl-4H-benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine D2 receptor and the serotonin reuptake site |
01/31/2012 | US8106042 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors |
01/31/2012 | US8106041 Combination product comprising an antagonist or inverse agonist of histamine receptor H3 and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs |
01/31/2012 | US8106016 Compounds and compositions for prevention of overdose of oxycodone |
01/31/2012 | US8106015 Method for enhancing immune response with peptide |
01/31/2012 | US8105774 Using peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PGC-1Beta) as tool to identify modulators for treatment of free radical associated disorders |
01/31/2012 | US8105631 Opioid agonist/antagonist combinations |
01/31/2012 | US8105581 Compositions and methods for inducing neuronal differentiation |
01/31/2012 | US8105580 Methods of using adipose derived stem cells to promote wound healing |
01/31/2012 | CA2546476C Pharmaceutical preparation containing gabapentin |
01/31/2012 | CA2463989C Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof |
01/31/2012 | CA2447990C Encapsulation of nanosuspensions in liposomes and microspheres |
01/31/2012 | CA2226087C Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
01/26/2012 | WO2012012798A2 Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases |
01/26/2012 | WO2012012712A2 Tricyclic proteasome activity enhancing compounds |
01/26/2012 | WO2012012676A2 Use of mir-29 for cell protection |
01/26/2012 | WO2012012656A2 Materials and methods for treating neurodegenerative diseases |
01/26/2012 | WO2012012410A2 Kappa opioid receptor agonists |
01/26/2012 | WO2012012370A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
01/26/2012 | WO2012012347A2 Methods of intravenous administration of glyburide and other drugs |
01/26/2012 | WO2012012339A2 Glycosylated acetaminophen pro-drug analogs |
01/26/2012 | WO2012012333A1 Topical treatment of neuropathic pain and methods of diagnosis |
01/26/2012 | WO2012012257A2 BIVALENT MULTIFUNCTIONAL LIGANDS TARGETING Aβ OLIGOMERS AS TREATMENT FOR ALZHEIMER'S DISEASE |
01/26/2012 | WO2012012147A2 Methods and compositions for treatment of multiple sclerosis |
01/26/2012 | WO2012011731A2 Method for separating and identifying calgranulin a as a dementia marker from blood cells |
01/26/2012 | WO2012011621A1 Amyloid-beta clearance |
01/26/2012 | WO2012011591A1 Fused heterocyclic compound and application thereof |
01/26/2012 | WO2012011549A1 P2x4 receptor antagonist |
01/26/2012 | WO2012011548A1 Nitrogen-containing heterocyclic derivative |
01/26/2012 | WO2012011486A1 Neuropathic pain reducing agent and antidepressant agent, each using neuropeptide |
01/26/2012 | WO2012011407A1 Therapeutic agent for disease accompanied by epileptic waves |
01/26/2012 | WO2012010896A1 Treatment of l-dopa, dopamine agonist and/or dopamine enhancer induced disorders |
01/26/2012 | WO2012010675A2 Bhlh proteins and their use as drugs |
01/26/2012 | WO2012010606A1 Hexacyclic polyketides as kinase inhibitors |
01/26/2012 | WO2012009973A1 Antiparkinsonian drug-loaded microsphere composition and use thereof |
01/26/2012 | WO2012009830A1 Methods for producing nerve cells from stem cells, nerve cells and uses thereof |
01/26/2012 | WO2012009823A1 Tranquilising/sedating pharmaceutical formulation based on neurosteroids and a phenothiazine derivative for use in mammals |
01/26/2012 | WO2011142691A3 Method for producing a neural matrix |
01/26/2012 | WO2011130347A3 Methods for enhancing axonal regeneration |
01/26/2012 | WO2011106226A3 Prolylhydroxylase inhibitors and methods of use |
01/26/2012 | WO2011081928A3 Compositions and methods for altering cocaine esterase activity |
01/26/2012 | WO2010143070A3 Amorphous varenicline tartrate co-precipitates |
01/26/2012 | US20120023600 Compositions and methods of use for antibodies of dickkopf-1 |
01/26/2012 | US20120022166 Methods for Modulating Macrophage Proliferation Using Polyamine Analogs |
01/26/2012 | US20120022163 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the therapy of prion diseases |
01/26/2012 | US20120022147 2, 6 xylidine derivatives for the treatment of pain |
01/26/2012 | US20120022138 Means for inhibiting the expression of ang2 |
01/26/2012 | US20120022125 Pyrrolidine triple reuptake inhibitors |
01/26/2012 | US20120022122 Treatment and prevention of deleterious effects associated with alcohol consumption |
01/26/2012 | US20120022114 Low-dose, non-irritating nicotine nasal composition to reduce the desire to smoke |
01/26/2012 | US20120022109 Oxadiazole derivatives |
01/26/2012 | US20120022108 Allosteric modulators of metabotropic glutamate receptors |
01/26/2012 | US20120022104 Pectin-containing jelly formulation |
01/26/2012 | US20120022103 Antagonists of the trpv1 receptor and uses thereof |
01/26/2012 | US20120022101 Salt and solvates of a tetrahydroisoquinoline derivative |
01/26/2012 | US20120022100 Organic compounds |
01/26/2012 | US20120022099 Novel polymorphic forms of an azabicyclo-trifluoromethyl benzamide derivative |
01/26/2012 | US20120022096 Pro-neurogenic compounds |
01/26/2012 | US20120022093 Crystalline forms of oxymorphone hydrochloride |
01/26/2012 | US20120022092 Protein kinase c inhibitors and uses thereof |
01/26/2012 | US20120022090 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators |
01/26/2012 | US20120022086 Catecholamine derivatives for obesity and neurological disorders |
01/26/2012 | US20120022083 Small molecule modulators of cell adhesion |
01/26/2012 | US20120022080 Plasminogen Activator Inhibitor-1 Inhibitor |
01/26/2012 | US20120022076 Derivatives of n-(arylamino)sulfonamides as inhibitors of mek |
01/26/2012 | US20120022074 Organic compounds |
01/26/2012 | US20120022072 Pterin analogs |
01/26/2012 | US20120022070 Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use |
01/26/2012 | US20120022069 Acrylamide compounds and the use thereof |
01/26/2012 | US20120022068 NOVEL HETEROCYCLIC NF-kB INHIBITORS |
01/26/2012 | US20120022064 Dihydroquinolinone derivatives |
01/26/2012 | US20120022058 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses |
01/26/2012 | US20120022056 Fused tricyclic derivatives for the treatment of psychotic disorders |
01/26/2012 | US20120022052 Small molecule inhibitors of kynurenine-3-monooxygenase |
01/26/2012 | US20120022051 Rapid onset liquid midazolam composition for buccal administration |
01/26/2012 | US20120022050 Histamine h3 inverse agonists and antagonists and methods of use thereof |
01/26/2012 | US20120022047 Process for the purification of eslicarbazepine acetate |
01/26/2012 | US20120022044 Triazole derivatives for treatment of alzheimer's disease |